Magnesium Chloride 20% Inj, 50ml

Manufacturer MYLAN Active Ingredient Magnesium Chloride Injection(mag NEE zhum KLOR ide) Pronunciation mag NEE zhum KLOR ide
It is used to treat or prevent low magnesium levels.
đŸˇī¸
Drug Class
Electrolyte Supplement; Anticonvulsant; Antiarrhythmic
đŸ§Ŧ
Pharmacologic Class
Mineral; Magnesium Salt
🤰
Pregnancy Category
Category B
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Magnesium chloride injection is a medicine given into a vein to treat very low levels of magnesium in the body, or to help with certain medical conditions like severe seizures in pregnancy or a specific type of irregular heartbeat. Magnesium is a natural substance in your body that is important for muscles, nerves, and heart function.
📋

How to Use This Medicine

To use this medication correctly, follow your doctor's instructions and carefully read all accompanying information. Take this medication exactly as directed, and be sure to follow all instructions provided. This drug is administered as an intravenous infusion, which means it is given into a vein over a specified period of time.

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

If you miss a dose, contact your doctor immediately to receive guidance on what to do next.
💡

Lifestyle & Tips

  • Report any unusual symptoms immediately to your healthcare provider.
  • Do not take other magnesium-containing products (e.g., antacids, laxatives) without consulting your doctor while receiving this injection.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Dosage is highly individualized based on indication and serum magnesium levels. For severe hypomagnesemia: 8-12 grams (66-99 mEq) IV over 24 hours. For Torsades de Pointes: 1-2 grams (8-16 mEq) IV over 5-20 minutes, followed by infusion if needed. For pre-eclampsia/eclampsia: Loading dose 4-6 grams (33-49 mEq) IV over 15-30 minutes, followed by maintenance infusion of 1-2 grams/hour (8-16 mEq/hour). Note: 20% solution (200 mg/mL) must be diluted prior to IV infusion.
Dose Range: 1 - 12 mg

Condition-Specific Dosing:

Hypomagnesemia (severe): 8-12 grams IV over 24 hours
Torsades de Pointes: 1-2 grams IV over 5-20 minutes
Pre-eclampsia/Eclampsia: Loading: 4-6 grams IV over 15-30 min; Maintenance: 1-2 grams/hour IV infusion
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established for routine use; specific protocols for severe hypomagnesemia or neonatal seizures may exist (e.g., 25-50 mg/kg/dose IV over 1-2 hours, repeated as needed).
Infant: Not established for routine use; specific protocols for severe hypomagnesemia or acute asthma may exist (e.g., 25-50 mg/kg/dose IV over 1-2 hours, repeated as needed).
Child: Hypomagnesemia: 25-50 mg/kg/dose (max 2 grams) IV over 2-4 hours, repeated as needed. Acute severe asthma: 25-50 mg/kg (max 2 grams) IV over 15-30 minutes.
Adolescent: Similar to adult dosing for specific indications, adjusted for weight and clinical status.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor serum magnesium and renal function closely.
Moderate: Reduce dose by 25-50% and/or extend dosing interval. Monitor serum magnesium and renal function frequently.
Severe: Contraindicated or significantly reduced dose (e.g., 50-75% reduction) with extreme caution and continuous monitoring of serum magnesium, reflexes, and respiratory rate. Risk of hypermagnesemia is high.
Dialysis: Contraindicated in patients with renal failure unless undergoing dialysis and serum magnesium is closely monitored. Magnesium is dialyzable.

Hepatic Impairment:

Mild: No specific dose adjustment required.
Moderate: No specific dose adjustment required.
Severe: No specific dose adjustment required.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Magnesium is an essential cofactor for numerous enzymatic reactions, including those involved in energy production, nucleic acid synthesis, and protein synthesis. It plays a crucial role in neuromuscular transmission, muscle contraction, and cardiac excitability. Magnesium acts as a physiological calcium channel blocker, stabilizing excitable membranes. In pre-eclampsia/eclampsia, it reduces acetylcholine release at the neuromuscular junction, causing vasodilation and reducing CNS irritability. In Torsades de Pointes, it blocks calcium influx, reducing early afterdepolarizations and prolonging the action potential duration.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV)
Tmax: Immediate (IV)
FoodEffect: Not applicable (IV)

Distribution:

Vd: Approximately 0.2-0.3 L/kg (distributes into bone, muscle, and soft tissues)
ProteinBinding: Approximately 25-30% (to albumin)
CnssPenetration: Limited (crosses blood-brain barrier slowly, but therapeutic levels can affect CNS)

Elimination:

HalfLife: Approximately 2-6 hours (plasma half-life, but varies with renal function)
Clearance: Primarily renal excretion; rate depends on glomerular filtration rate
ExcretionRoute: Renal (urine)
Unchanged: Nearly 100%
âąī¸

Pharmacodynamics

OnsetOfAction: Immediate (IV)
PeakEffect: Minutes (IV)
DurationOfAction: Approximately 30 minutes to 4 hours (depending on dose, renal function, and indication)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. Immediately contact your doctor or seek medical attention if you experience any of the following symptoms, which may indicate a serious reaction:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Flushing
Excessive sweating
Dizziness or fainting
Feeling sluggish
Feeling cold
Shortness of breath

Other Possible Side Effects

Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. Contact your doctor or seek medical help if you experience any of the following side effects or if they persist or bother you:

Diarrhea

Note: This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Feeling very tired or weak
  • Difficulty breathing or slow breathing
  • Feeling dizzy or lightheaded
  • Blurred vision
  • Muscle weakness or limpness
  • Slow heartbeat
  • Flushing or sweating
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a history of heart disease or kidney disease, as these conditions may affect your ability to take this medication safely.

This list is not exhaustive, and it is crucial to discuss all your health problems and medications with your doctor. Please provide your doctor and pharmacist with a comprehensive list of:

All prescription and over-the-counter (OTC) medications you are currently taking
Any natural products or vitamins you are using
* All your health problems, including any medical conditions or diseases

To ensure your safety, do not start, stop, or change the dose of any medication without first consulting your doctor. It is vital to verify that it is safe to take this medication with all your other drugs and health conditions.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Discuss the details with your doctor.

This medication may contain aluminum, which can increase the risk of aluminum toxicity with long-term use. This risk is particularly higher if you have kidney problems or if you are a premature infant. It is crucial to discuss this potential risk with your doctor.

If you are pregnant, planning to become pregnant, or are breastfeeding, you must notify your doctor. You and your doctor will need to weigh the benefits and risks of this medication to both you and your baby to make an informed decision.
🆘

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Flushing
  • Thirst
  • Hypotension (low blood pressure)
  • Drowsiness
  • Confusion
  • Loss of deep tendon reflexes
  • Muscle weakness
  • Respiratory depression (slow or shallow breathing)
  • Bradycardia (slow heart rate)
  • Cardiac arrest

What to Do:

Immediately discontinue magnesium administration. Administer intravenous calcium gluconate (10 mL of 10% solution) slowly to counteract magnesium's effects. Provide respiratory support (e.g., mechanical ventilation) if needed. Administer IV fluids to promote renal excretion. Hemodialysis may be necessary in severe cases, especially with renal impairment. Call 1-800-222-1222 (Poison Control).

Drug Interactions

🔴

Major Interactions

  • Neuromuscular blocking agents (e.g., rocuronium, vecuronium): Potentiates effects, leading to prolonged paralysis.
  • Calcium channel blockers (e.g., nifedipine, verapamil): May enhance hypotensive and neuromuscular depressant effects.
  • CNS depressants (e.g., opioids, benzodiazepines): Additive CNS depression.
  • Digoxin: High magnesium levels can reduce digoxin's effects; hypomagnesemia can potentiate digoxin toxicity.
🟡

Moderate Interactions

  • Diuretics (loop and thiazide): May increase renal excretion of magnesium, leading to hypomagnesemia (chronic use).
  • Aminoglycosides (e.g., gentamicin): May increase renal excretion of magnesium.
  • Tetracyclines/Quinolones (oral): Magnesium can chelate these antibiotics, reducing absorption (not relevant for IV magnesium chloride).

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Magnesium

Rationale: To establish baseline levels and guide initial dosing.

Timing: Prior to initiation of therapy.

Renal Function (BUN, Creatinine)

Rationale: Magnesium is primarily renally excreted; impaired renal function increases risk of toxicity.

Timing: Prior to initiation of therapy.

Vital Signs (BP, HR, RR)

Rationale: To establish baseline and monitor for adverse effects (hypotension, respiratory depression).

Timing: Prior to initiation of therapy.

Deep Tendon Reflexes (DTRs)

Rationale: To establish baseline and monitor for signs of hypermagnesemia (loss of DTRs).

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Serum Magnesium

Frequency: Every 4-6 hours during continuous infusion, or as clinically indicated.

Target: Therapeutic range varies by indication (e.g., 4-7 mEq/L for pre-eclampsia/eclampsia, 1.5-2.5 mEq/L for hypomagnesemia correction).

Action Threshold: Levels > 7 mEq/L (loss of DTRs), > 10 mEq/L (respiratory depression), > 12 mEq/L (cardiac arrest) require immediate intervention.

Deep Tendon Reflexes (DTRs)

Frequency: Hourly during continuous infusion, or frequently as clinically indicated.

Target: Present (2+)

Action Threshold: Diminished or absent DTRs indicate hypermagnesemia; hold infusion.

Respiratory Rate

Frequency: Hourly during continuous infusion, or frequently as clinically indicated.

Target: > 12 breaths/min (adults)

Action Threshold: < 12 breaths/min indicates respiratory depression; hold infusion.

Urine Output

Frequency: Hourly during continuous infusion.

Target: > 25-30 mL/hour (adults)

Action Threshold: < 25 mL/hour indicates impaired renal excretion; hold infusion.

Blood Pressure

Frequency: Hourly during continuous infusion, or frequently as clinically indicated.

Target: Within patient's normal range, avoiding hypotension.

Action Threshold: Significant hypotension; hold infusion.

ECG

Frequency: Continuously or periodically, especially with rapid infusion or high doses.

Target: Normal rhythm, PR/QRS/QT intervals.

Action Threshold: Prolonged PR, QRS, QT intervals, heart block, bradycardia, asystole.

đŸ‘ī¸

Symptom Monitoring

  • Flushing
  • Sweating
  • Hypotension
  • Sedation
  • Confusion
  • Muscle weakness
  • Loss of deep tendon reflexes
  • Respiratory depression
  • Bradycardia
  • Cardiac arrest

Special Patient Groups

🤰

Pregnancy

Magnesium chloride is considered Category B. It is commonly used in pregnancy for the prevention and treatment of seizures in pre-eclampsia and eclampsia. However, prolonged use (more than 5-7 days) during pregnancy, especially in the third trimester, may lead to fetal bone abnormalities (e.g., hypocalcemia, osteopenia) and neonatal hypotonia or respiratory depression. Close monitoring of both mother and fetus is essential.

Trimester-Specific Risks:

First Trimester: Generally considered safe if indicated for severe maternal conditions; limited data on specific risks.
Second Trimester: Generally considered safe if indicated; monitor for maternal adverse effects.
Third Trimester: Risk of fetal bone abnormalities (hypocalcemia, osteopenia) with prolonged exposure (>5-7 days) and neonatal hypotonia/respiratory depression if administered close to delivery. Use lowest effective dose for shortest duration.
🤱

Lactation

Magnesium is naturally present in breast milk. Excretion into breast milk is minimal and not expected to cause adverse effects in a breastfed infant when administered therapeutically to the mother. Considered L1 (safest).

Infant Risk: Low risk of adverse effects to the infant.
đŸ‘ļ

Pediatric Use

Use with caution. Dosing must be carefully calculated based on weight and indication. Neonates and infants are particularly susceptible to hypermagnesemia due to immature renal function. Close monitoring of serum magnesium, vital signs, and reflexes is crucial.

👴

Geriatric Use

Use with caution. Elderly patients may have age-related decline in renal function, increasing the risk of hypermagnesemia. Lower doses and slower infusion rates may be necessary. Close monitoring of renal function, serum magnesium, and clinical status is essential.

Clinical Information

💎

Clinical Pearls

  • Magnesium chloride 20% solution is highly concentrated (200 mg/mL) and MUST be diluted before intravenous administration to prevent irritation and ensure safe infusion.
  • Always have calcium gluconate (10% solution) readily available as an antidote for severe hypermagnesemia.
  • Monitor deep tendon reflexes, respiratory rate, and urine output frequently during magnesium infusions, as these are early indicators of toxicity.
  • Patients with impaired renal function are at significantly higher risk of hypermagnesemia and require substantial dose adjustments and more frequent monitoring.
  • Magnesium is essential for potassium and calcium homeostasis; hypomagnesemia often coexists with hypokalemia and hypocalcemia and may need to be corrected first for other electrolyte abnormalities to resolve.
🔄

Alternative Therapies

  • Magnesium Sulfate (most common IV magnesium salt)
  • Magnesium Gluconate (oral)
  • Magnesium Oxide (oral)
  • Magnesium Citrate (oral)
💰

Cost & Coverage

Average Cost: Varies widely per 50ml vial (20% solution)
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional or pharmacist, do not flush medications down the toilet or drain. If you are unsure about the proper disposal method, consult your pharmacist, who can also inform you about potential drug take-back programs in your area. Some medications may come with an additional patient information leaflet; check with your pharmacist for more information. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it occurred to ensure prompt and effective treatment.